The University of Chicago Header Logo

Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy.

Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy. Nat Rev Nephrol. 2016 10; 12(10):583-4.

View in: PubMed